Search clinical trials for: PB119

Total 3 results

PegBio Co., Ltd.

Not yet recruiting

Study to Evaluate the Pharmacokinetic Characteristics of Pegylated Exenatide Injection (PB-119) in Subjects With Different Degrees of Renal Insufficiency and Matched Subjects With Normal Renal Function

Type2Diabetes

China
Tenet Medicines

Terminated

Efficacy and Safety of VB119 in Subjects With Minimal Change Disease (MCD) and Focal Segmental Glomerulosclerosis (FSGS)

Focal Segmental Glomerulosclerosis | Minimal Change Disease

United States
Tenet Medicines

Active, not recruiting

Efficacy and Safety of VB119 in Subjects With Membranous Nephropathy

Membranous Nephropathy

United States

3

Subscribe